Hanjing Xie
发表
J. Bergh,
S. Sim,
J. Lövrot,
2018,
Pharmacogenomics.
Hanjing Xie,
Moustapha Hassan,
A. Rane,
2002,
European journal of pharmacology.
CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients.
S. Margolin,
J. Lindh,
Hanjing Xie,
2013,
Pharmacogenomics (London).
J. Bergh,
M. Browall,
Y. Brandberg,
2016,
Supportive Care in Cancer.
E. Kimby,
U. Yasar,
Hanjing Xie,
2006,
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
J. Bergh,
S. Sim,
Hanjing Xie,
2018,
Pharmacogenomics.
C. Rolny,
U. Harmenberg,
Hanjing Xie,
2017,
Oncoimmunology.
J. Bergh,
Hanjing Xie,
T. Hatschek,
2014,
Cancer Chemotherapy and Pharmacology.
E. Kimby,
L. Möllgård,
Hanjing Xie,
2005,
European journal of haematology.
Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer
J. Bergh,
L. Lindström,
J. Lövrot,
2015,
Molecular oncology.
J. Astermark,
R. Ljung,
Hanjing Xie,
2022,
Haemophilia.
U. Yasar,
Hanjing Xie,
Moustapha Hassan,
2003,
The Pharmacogenomics Journal.
J. Bergh,
S. Sim,
Hanjing Xie,
2018,
Pharmacogenomics.